research use only

Ampalex (CX-516) GluR agonist

Cat.No.S0165

Ampalex (CX-516, Ampakine CX 516, BDP-12, SPD 420) is a positive allosteric modulator of AMPA receptor and exhibits potential for the treatment of Alzheimer's disease, schizophrenia and mild cognitive impairment (MCI).
Ampalex (CX-516) GluR agonist Chemical Structure

Chemical Structure

Molecular Weight: 241.29

Quality Control

Chemical Information, Storage & Stability

Molecular Weight 241.29 Formula

C14H15N3O

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 154235-83-3 -- Storage of Stock Solutions

Synonyms Ampakine CX 516, BDP-12, SPD 420 Smiles C1CCN(CC1)C(=O)C2=CC3=NC=CN=C3C=C2

Solubility

In vitro
Batch:

DMSO : 48 mg/mL ( (198.93 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Water : 48 mg/mL

Ethanol : 48 mg/mL

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

Targets/IC50/Ki
AMPA receptor [1]
References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT00235352 Completed
Schizophrenia
North Suffolk Mental Health Association|RespireRx
February 2002 Phase 2|Phase 3

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.

Signaling Pathway Map